Silo Pharma, Inc.
SILO
$0.39
$0.023.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Cost of Revenue | 20.70K | 20.70K | 20.70K | 1.50K | 1.50K |
| Gross Profit | -2.70K | -2.70K | -2.70K | 16.60K | 16.60K |
| SG&A Expenses | 578.70K | 477.90K | 605.20K | 547.90K | 516.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.61M | 804.60K | 1.17M | 1.27M | 1.11M |
| Operating Income | -1.59M | -786.50K | -1.15M | -1.25M | -1.09M |
| Income Before Tax | -1.65M | -881.50K | -1.11M | -1.20M | -1.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.65M | -881.50K | -1.11M | -1.20M | -1.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.65M | -881.50K | -1.11M | -1.20M | -1.03M |
| EBIT | -1.59M | -786.50K | -1.15M | -1.25M | -1.09M |
| EBITDA | -1.59M | -783.60K | -1.15M | -1.25M | -1.09M |
| EPS Basic | -0.12 | -0.07 | -0.12 | -0.19 | -0.23 |
| Normalized Basic EPS | -0.08 | -0.04 | -0.07 | -0.12 | -0.14 |
| EPS Diluted | -0.12 | -0.07 | -0.12 | -0.19 | -0.23 |
| Normalized Diluted EPS | -0.08 | -0.04 | -0.07 | -0.12 | -0.14 |
| Average Basic Shares Outstanding | 13.71M | 13.38M | 9.33M | 6.28M | 4.48M |
| Average Diluted Shares Outstanding | 13.71M | 13.38M | 9.33M | 6.28M | 4.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |